Ryman Healthcare Limited Stock Analysis
| RHCGF Stock | USD 1.41 0.00 0.00% |
Ryman Healthcare holds a debt-to-equity ratio of 0.762. Ryman Healthcare's financial risk is the risk to Ryman Healthcare stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Ryman Healthcare's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Ryman Healthcare's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Ryman Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Ryman Healthcare's stakeholders.
For many companies, including Ryman Healthcare, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Ryman Healthcare Limited, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Ryman Healthcare's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Ryman Healthcare's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Ryman Healthcare is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Ryman Healthcare to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Ryman Healthcare is said to be less leveraged. If creditors hold a majority of Ryman Healthcare's assets, the Company is said to be highly leveraged.
Ryman Healthcare Limited is undervalued with Real Value of 1.5 and Hype Value of 1.41. The main objective of Ryman Healthcare pink sheet analysis is to determine its intrinsic value, which is an estimate of what Ryman Healthcare Limited is worth, separate from its market price. There are two main types of Ryman Healthcare's stock analysis: fundamental analysis and technical analysis.
The Ryman Healthcare pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ryman Healthcare's ongoing operational relationships across important fundamental and technical indicators.
Ryman |
Ryman Pink Sheet Analysis Notes
About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.08. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ryman Healthcare has Price/Earnings To Growth (PEG) ratio of 2.97. The entity last dividend was issued on the 8th of December 2022. The firm had 5:1 split on the 26th of January 2007. Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company was founded in 1984 and is based in Christchurch, New Zealand. Ryman Healthcare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 6700 people.The quote for Ryman Healthcare Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Ryman Healthcare Limited contact the company at 64 3 366 4069 or learn more at https://www.rymanhealthcare.co.nz.Ryman Healthcare Investment Alerts
| Ryman Healthcare generated a negative expected return over the last 90 days | |
| Ryman Healthcare may become a speculative penny stock | |
| Ryman Healthcare Limited has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity. | |
| About 17.0% of Ryman Healthcare outstanding shares are owned by corporate insiders |
Ryman Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ryman Healthcare's market, we take the total number of its shares issued and multiply it by Ryman Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Ryman Profitablity
The company has Profit Margin (PM) of 1.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.02) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.02.Technical Drivers
As of the 19th of February, Ryman Healthcare holds the Variance of 5.72, coefficient of variation of (812.40), and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ryman Healthcare, as well as the relationship between them. Please check Ryman Healthcare coefficient of variation, as well as the relationship between the total risk alpha and skewness to decide if Ryman Healthcare is priced some-what accurately, providing market reflects its current price of 1.41 per share. Please also confirm Ryman Healthcare information ratio, which is currently at (0.15) to check out the company can sustain itself at a future point.Ryman Healthcare Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
Ryman Healthcare Predictive Daily Indicators
Ryman Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ryman Healthcare pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Ryman Healthcare Forecast Models
Ryman Healthcare's time-series forecasting models are one of many Ryman Healthcare's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ryman Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Ryman Healthcare Debt to Cash Allocation
Many companies such as Ryman Healthcare, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Ryman Healthcare Limited has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity.Ryman Healthcare Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Ryman Healthcare's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Ryman Healthcare, which in turn will lower the firm's financial flexibility.About Ryman Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Ryman Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ryman shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Ryman Healthcare. By using and applying Ryman Pink Sheet analysis, traders can create a robust methodology for identifying Ryman entry and exit points for their positions.
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company was founded in 1984 and is based in Christchurch, New Zealand. Ryman Healthcare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 6700 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Ryman Healthcare to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Complementary Tools for Ryman Pink Sheet analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |